Special Counsel Jill Wright was quoted in a Modern Healthcare article, “HHS Investigators Will Prioritize Causes for High Drug Prices in 2017,” on November 11, 2016. The article discussed top issues U.S. Department of Health and Human Services Office of Inspector General (OIG) hopes to tackle in 2017, including a heightened focus on drug costs. One area the agency plans to review is whether the Centers for Medicare & Medicaid Services can save money if U.S. providers purchased smaller-size single-use drug vials that are used in other countries.
Wright said OIG might see the vial issue as a relatively simple way to curb waste for both providers and payers, and also represents a chance to bring the issue to the FDA, which approves vial sizes. She said, “It’s something that seems to be easy to do, and it might be sort of low-hanging fruit as far as preventing tax payers dollars from being wasted.”
Wright said OIG might see the vial issue as a relatively simple way to curb waste for both providers and payers, and also represents a chance to bring the issue to the FDA, which approves vial sizes. She said, “It’s something that seems to be easy to do, and it might be sort of low-hanging fruit as far as preventing tax payers dollars from being wasted.”
Related News
24 April 2024
In the News
Judith Waltz Discusses Nursing Home Staffing Mandate, Potential Legal Challenges
Foley & Lardner LLP partner Judith Waltz offers insight on a new nursing home staffing rule from the U.S. Department of Health and Human Services and its impact on the industry in the Bloomberg Law article, “Nursing Homes, HHS on Collision Path Over Staffing Mandate.”
23 April 2024
In the News
David Sanders Discusses Lessons Learned from General Counsel Leadership Program
Foley & Lardner LLP partner David Sanders recently joined a panel discussion with members of The Vanguard Network’s General Counsels Advisory Group to discuss the evolving role of the general counsel.
23 April 2024
In the News
Claire Marblestone Discusses HHS Final Rule on Protected Health Information Disclosure
Foley & Lardner LLP Claire Marblestone assessed the U.S. Department of Health and Human Services’ final rule that bars providers, health plans, and other entities covered by the Health Insurance Portability and Accountability Act from disclosing protected health information in a Healthcare Dive article.